| Style | Citing Format |
|---|---|
| MLA | Safavi SMR, Honarmand A, Taheri P. "Specify the Effect of Intranasal and Intravenous Remifentanil on Hemodynamic Changes After Induction and Tracheal Intubation and Comparing With Control Group." Journal of Isfahan Medical School, vol. 43, no. 817, 2025, pp. 598-607. |
| APA | Safavi SMR, Honarmand A, Taheri P (2025). Specify the Effect of Intranasal and Intravenous Remifentanil on Hemodynamic Changes After Induction and Tracheal Intubation and Comparing With Control Group. Journal of Isfahan Medical School, 43(817), 598-607. |
| Chicago | Safavi SMR, Honarmand A, Taheri P. "Specify the Effect of Intranasal and Intravenous Remifentanil on Hemodynamic Changes After Induction and Tracheal Intubation and Comparing With Control Group." Journal of Isfahan Medical School 43, no. 817 (2025): 598-607. |
| Harvard | Safavi SMR, Honarmand A, Taheri P (2025) 'Specify the Effect of Intranasal and Intravenous Remifentanil on Hemodynamic Changes After Induction and Tracheal Intubation and Comparing With Control Group', Journal of Isfahan Medical School, 43(817), pp. 598-607. |
| Vancouver | Safavi SMR, Honarmand A, Taheri P. Specify the Effect of Intranasal and Intravenous Remifentanil on Hemodynamic Changes After Induction and Tracheal Intubation and Comparing With Control Group. Journal of Isfahan Medical School. 2025;43(817):598-607. |
| BibTex | @article{ author = {Safavi SMR and Honarmand A and Taheri P}, title = {Specify the Effect of Intranasal and Intravenous Remifentanil on Hemodynamic Changes After Induction and Tracheal Intubation and Comparing With Control Group}, journal = {Journal of Isfahan Medical School}, volume = {43}, number = {817}, pages = {598-607}, year = {2025} } |
| RIS | TY - JOUR AU - Safavi SMR AU - Honarmand A AU - Taheri P TI - Specify the Effect of Intranasal and Intravenous Remifentanil on Hemodynamic Changes After Induction and Tracheal Intubation and Comparing With Control Group JO - Journal of Isfahan Medical School VL - 43 IS - 817 SP - 598 EP - 607 PY - 2025 ER - |